vs
Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $28.5M, roughly 1.1× Creative Media & Community Trust Corp). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -125.8%, a 93.6% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -4.5%). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -8.5%).
Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CMCT vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $28.5M | $31.1M |
| Net Profit | $-11.4M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | -125.6% | -9.9% |
| Net Margin | -125.8% | -32.1% |
| Revenue YoY | 3.6% | -4.5% |
| Net Profit YoY | -11.4% | -52.0% |
| EPS (diluted) | $-3.89 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $28.5M | — | ||
| Q3 25 | $26.2M | $31.1M | ||
| Q2 25 | $29.7M | — | ||
| Q1 25 | $32.3M | $35.2M | ||
| Q4 24 | $27.5M | $32.6M | ||
| Q3 24 | $28.6M | $24.7M | ||
| Q2 24 | $34.4M | — | ||
| Q1 24 | $34.0M | $35.7M |
| Q4 25 | $-11.4M | — | ||
| Q3 25 | $-12.5M | $-10.0M | ||
| Q2 25 | $-9.0M | — | ||
| Q1 25 | $-6.1M | $-14.8M | ||
| Q4 24 | $-10.3M | $-6.6M | ||
| Q3 24 | $-10.4M | $-16.2M | ||
| Q2 24 | $-796.0K | — | ||
| Q1 24 | $-3.7M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -125.6% | — | ||
| Q3 25 | -47.7% | -9.9% | ||
| Q2 25 | -30.3% | — | ||
| Q1 25 | -19.0% | -25.7% | ||
| Q4 24 | -128.8% | -6.0% | ||
| Q3 24 | -36.9% | -46.9% | ||
| Q2 24 | -1.6% | — | ||
| Q1 24 | -10.7% | -2.5% |
| Q4 25 | -125.8% | — | ||
| Q3 25 | -47.5% | -32.1% | ||
| Q2 25 | -30.3% | — | ||
| Q1 25 | -18.9% | -42.0% | ||
| Q4 24 | -129.8% | -20.2% | ||
| Q3 24 | -36.3% | -65.7% | ||
| Q2 24 | -2.3% | — | ||
| Q1 24 | -11.0% | 43.8% |
| Q4 25 | $-3.89 | — | ||
| Q3 25 | $-23.52 | $-0.29 | ||
| Q2 25 | $-18.94 | — | ||
| Q1 25 | $-20.73 | $-0.47 | ||
| Q4 24 | $97.71 | $-0.25 | ||
| Q3 24 | $-305.04 | $-0.53 | ||
| Q2 24 | $-98.64 | — | ||
| Q1 24 | $-125.46 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.4M | $18.9M |
| Total DebtLower is stronger | $509.8M | $136.0M |
| Stockholders' EquityBook value | $265.4M | $-10.5M |
| Total Assets | $859.2M | $235.2M |
| Debt / EquityLower = less leverage | 1.92× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.4M | — | ||
| Q3 25 | $17.3M | $18.9M | ||
| Q2 25 | $27.8M | — | ||
| Q1 25 | $19.8M | $5.4M | ||
| Q4 24 | $20.3M | $9.5M | ||
| Q3 24 | $18.5M | — | ||
| Q2 24 | $29.3M | — | ||
| Q1 24 | $21.3M | — |
| Q4 25 | $509.8M | — | ||
| Q3 25 | $527.8M | $136.0M | ||
| Q2 25 | $535.6M | — | ||
| Q1 25 | $512.7M | $124.9M | ||
| Q4 24 | $505.7M | $111.3M | ||
| Q3 24 | $478.3M | $106.3M | ||
| Q2 24 | $485.1M | — | ||
| Q1 24 | $472.8M | $97.1M |
| Q4 25 | $265.4M | — | ||
| Q3 25 | $281.9M | $-10.5M | ||
| Q2 25 | $287.1M | — | ||
| Q1 25 | $293.0M | $2.2M | ||
| Q4 24 | $304.5M | $15.4M | ||
| Q3 24 | $321.0M | $-3.9M | ||
| Q2 24 | $351.1M | — | ||
| Q1 24 | $369.9M | $17.7M |
| Q4 25 | $859.2M | — | ||
| Q3 25 | $871.8M | $235.2M | ||
| Q2 25 | $885.0M | — | ||
| Q1 25 | $882.3M | $237.7M | ||
| Q4 24 | $889.6M | $255.4M | ||
| Q3 24 | $868.0M | $246.8M | ||
| Q2 24 | $891.2M | — | ||
| Q1 24 | $887.5M | $246.2M |
| Q4 25 | 1.92× | — | ||
| Q3 25 | 1.87× | — | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.75× | 56.05× | ||
| Q4 24 | 1.66× | 7.20× | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.38× | — | ||
| Q1 24 | 1.28× | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.8M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | — | ||
| Q3 25 | $3.7M | $1.8M | ||
| Q2 25 | $-2.5M | — | ||
| Q1 25 | $1.2M | $1.2M | ||
| Q4 24 | $17.0M | $-6.1M | ||
| Q3 24 | $10.3M | $-613.0K | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $1.6M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMCT
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
